Install Findmino as an app for the best experience!
Health & Social Care
Duration
4 years
Level
Bachelor
Outlook
Growing
This degree focuses on the science and clinical application of advanced therapeutic technologies, including cell therapy, gene therapy, and biopharmaceutical manufacturing. You study how cutting-edge treatments are designed, produced, and translated from laboratory research into clinical use. Modules cover molecular biology, bioprocessing, regulatory affairs, and quality systems relevant to Ireland's thriving biologics and biopharma sector. Practical work includes laboratory sessions in cell culture, gene editing techniques, and analytical methods, alongside industry placements with leading advanced therapy manufacturers. A typical week combines lectures, laboratory practicals, tutorials, and self-directed study, giving you both scientific rigour and real-world industry readiness.
Entry is through the CAO and typically requires six subjects in the Leaving Certificate, including a minimum grade in English and Mathematics. Higher Level Biology and Chemistry are strongly recommended, as the programme is scientifically demanding. CAO points for this programme at RCSI are competitive, reflecting its specialist focus and limited places. If you do not meet direct entry requirements, a relevant QQI Level 5 or Level 6 PLC in Science or Biopharmaceutical Technology at a College of Further Education can provide a recognised progression route. Mature applicants aged 23 or over may apply directly to RCSI, and HEAR and DARE schemes are available for students from socioeconomically disadvantaged backgrounds or with disabilities.
Demand for graduates in advanced therapeutic technologies in Ireland is strong and growing, driven by sustained foreign direct investment in biopharma and a national pipeline of cell and gene therapy projects. Ireland is one of Europe's leading biologics manufacturing hubs, meaning local employment opportunities are substantial and varied. Salaries for entry-level roles typically range from approximately €32,000 to €45,000 per year, with experienced professionals in senior manufacturing or regulatory roles earning considerably more. The specialist nature of this degree gives graduates a competitive advantage in a talent-scarce market.
Artificial intelligence is increasingly used in bioprocess optimisation, predictive quality control, and the analysis of large genomic and proteomic datasets relevant to advanced therapies. You will likely encounter AI-assisted tools in analytical workflows, batch record analysis, and regulatory document management during your studies and placements. While AI augments many technical processes, the expert human judgement required in GMP environments, clinical translation, and patient safety decisions means graduate roles remain highly valued. Staying current with AI applications in bioprocessing will be an ongoing professional development expectation throughout your career.
1 CAO course lead to this qualification. Points shown are last year's Round 1 score.
Providers and indicative points are curated with AI support. Always double-check with the institution itself.
How to apply
Advanced Therapeutic Technologies at BSc (Hons) level in Ireland is typically offered as a specialist or postgraduate-entry programme; applicants apply directly to the institution rather than through the CAO. RCSI and similar health sciences institutions require applicants to hold a relevant prior qualification and apply via the institution's own postgraduate or direct-entry admissions portal.
This degree prepares you to work directly with individuals and communities affected by substance misuse, behavioural addictions, and related mental...
4 years
BachelorApplied Social Care at honours degree level prepares you to work directly with vulnerable individuals and communities across a wide range of...
4 years
Other studies, careers, ideas and blogs you might not know yet.
We use functional cookies and — with your consent — cookies for preferences, statistics and marketing.